St. Luke's Mid America Heart Institute, Kansas City (United States of America)
Follow
Contributor content
Presentation
Effect of acoramidis on improvement or maintenance of heart failure-related health status as assessed by Kansas City Cardiomyopathy Questionnaire Overall Summary score (KCCQ-OS) in ATTRibute-CM
